♟ Should You "Sell in May and Go Away"?

If history is any indicator, it's time to shift your approach to trading... [Trade of the Day Logo] [hero]( ["The last time the markets faced a serious debt ceiling debate, the S&P 500 dropped 19%. Is that what we're facing here in 2023?"]( Bryan Bottarelli, Head Trade Tactician, Monument Traders Alliance [Bryan Bottarelli] We just closed the books on April 2023, which was the Dow's strongest month since January. But now that the calendar has turned to May, it's important to take note of one of the most long-standing adages on Wall Street... "Sell in May and go away." If you follow historical and seasonal trends from the Stock Trader's Almanac, then you're most likely familiar with this saying. It's based on the market's best six months of the year - versus the market's worst six months of the year. Historically speaking, the top-performing six-month rolling period, on average, has been November through April. Since 1990, the S&P 500 has gained roughly 7% from November to April - compared with an average gain of about 2% from May to October. Therefore, the start of May officially ends this historically strong period - and thus, we get the old Wall Street saying. [This ONE Weekly Trade Is on Fire]( [Watch This Video TPU 85]( Former CBOE Trader Dishes the Secret to His [83% Win Rate]( Now he's GUARANTEEING he beats it! [You have to watch this.]( Combine this seasonal pattern with the coming battle over the debt ceiling, and we could most certainly see this pattern play out again here in 2023. Therefore, until it's proven otherwise, I believe it's now time to adopt a more defensive approach to your trading. [Is It Time for a Shift in the Markets]( Picking up on this pattern, Barron's predicts that we could be headed for a "summer of discontent." The last time the markets were faced with a serious debt ceiling debate - which was back in 2011 - it resulted in the first-ever Standard and Poor's downgrade of the U.S. government from an AAA rating. In response, the S&P 500 dropped 19%. Is that what we're facing here in 2023? It's anyone's guess, but as traders, we must be prepared - and pulling from historical trends is a good place to start. [Logo] YOUR ACTION PLAN That's precisely what we're doing inside [The War Room](. We'll be shifting our approach to generate consistent wins in the market, just as we did through the first four months of 2023, when we had a 74% win rate. And right now, we're guaranteeing all members will receive at least 252 winning trades in their first 12 months. [To join us in The War Room, click HERE]( [Yours Free! Top FIVE Dividend Stocks Right Now]( Marc Lichtenfeld - income expert and author of Get Rich with Dividends - is giving away his Ultimate Dividend Package... completely free of charge! You'll discover... - An "A"-rated, ultra-safe dividend stock with a huge 8% yield - Three of Marc's favorite "Extreme Dividend" stocks, which could supercharge your income - And finally, Marc's No. 1 dividend stock for a LIFETIME of income. [Click here to get the names and ticker symbols now](... before the download link expires. **NO CREDIT CARD REQUIRED!** [Chart] MONDAY MARKET MINUTE - General Motors Revving Up. The auto giant was up 3% in premarket after Morgan Stanley upgraded it to "Overweight" from "Equal Weight." Could this trigger an upside push? Tracking. - Bed Bath & Beyond's Pain Is TJX's Gain? Now that Bed Bath & Beyond (BBBY) filed for bankruptcy protection and announced inventory liquidation and the closing of 400 stores, a prime opportunity could open up for TJX Companies (TJX). Eighty percent of BBBY's stores are within 5 miles of a TJX store (such as Home Goods, Marshalls and T.J. Maxx). - JPMorgan Rises on First Republic Rescue. JPMorgan (JPM) acquired the substantial majority of assets and assumed the deposits and certain other liabilities of First Republic Bank (FRC). This news should add a sense of calm to the markets. - Getty Getting Interest. After Getty's (GETY) perceived low valuation regarding its dominant market position, investors are looking at upside for the visual media company. Shares are down 80% from SPAC-crazed highs, and now a rebound seems a lot more probable. - Iveric Bio Enters Agreement With Astellas Pharma. Iveric Bio (ISEE) was up 15% in premarket trading after Astellas Pharma (ALPMY) and ISEE announced they entered into a definitive agreement. Under that agreement, ALPMY has agreed to acquire 100% of the outstanding shares of ISEE for $40 per share in cash, for a total equity value of approximately $5.9 billion. INSIGHTS YOU MAY HAVE MISSED [Oil Pumpjack]( [Why I'm Bullish on Energy]( [Plant in the Shape of an Arrow]( [The Perfect Income/Growth Strategy]( [You Can Bank On This New Pick]( [Golden Income Opportunity in the Rubble]( [Board of Trade Building in Chicago]( [The First Thing They Teach You on the CBOE]( [Instagram]( [Follow Us on Instagram!]( [FACEBOOK]( [TWITTER]( [Trade of the Day App Banner]( [Monument Traders Alliance] Monument Traders Alliance You are receiving this email because you subscribed to Trade of the Day. To unsubscribe from Trade of the Day, [click here](. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 [Website]( | [Privacy Policy]( Keep the emails you value from falling into your spam folder. [Whitelist Trade of the Day](. © 2023 Monument Traders Alliance, LLC | All Rights Reserved --------------------------------------------------------------- Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.